2014 - 04 - 14
Dr. Anna Golebiewska, Researcher at the Norlux Neuro-Oncology Laboratory
“Brain cancer is a dreadful and often incurable disease. As a researcher working within a Neuro-Oncology laboratory directed by Dr. Simone Niclou in CRP-Santé, I try to understand the aberrant biology of tumor cells and its consequences for treatment. We use the knowledge acquired in the lab to design novel therapeutics that will hopefully provide patients with a better treatment and improve their quality of life. Progress and team work are the only hope to fight this devastating disease”.
Dr. Jacques Zimmer, Senior Researcher at the Laboratory of Immunogenetics and Allergology
“Natural Killer (NK) cells are a subtype of white blood cells and they are very important for our defense against infections and tumors. I am happy to contribute, together with my collaborators at the Department of Infection and Immunity, to the progressive discovery of their secrets, so that they may be used more and more for the treatment of infections and cancer in the forthcoming years”.
Dr. Alaa Al Kerwi, Senior Researcher at the Centre for Health Studies :
"As a Senior Researcher, interested in cardiovascular health of the general population, I believe that nutrition is a key element that determines the treatment and control of cardio-metabolic risk factors. Empowered by concrete international collaboration to share experiences, reinforce research capacity, and broaden horizons, I’m committed to progress the fight against cardiovascular diseases."
Dr. Daniel Witte, Project leader of the Luxembourg Cohort:
“I have worked in Denmark with an international study which showed the benefits and implications of screening for diabetes and cardiovascular disease risk in the general population. The Luxembourg Cohort will allow us to investigate whether early detection of the pre-clinical phases of diabetes and cardiovascular disease could also be of benefit for the population of Luxembourg”.
Dr. Bassam Janji, Senior Researcher at the Laboratory of Experimental Hemato-Oncology
“I was taught that the way of progress was neither swift nor easy (Marie Curie). After decades of disappointment, cancer immunotherapy has recently emerged as a promising treatment of several cancers for which conventional therapies have failed. I am confident that this therapy will represent the greatest hope for patients currently facing the disease”.